The current AB market cap is 41.14M. The company's latest EPS is EUR -0.2302 and P/E is -3.43.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 1.57M | 1.58M | 1.61M | 958k | 970k |
Operating Income | -17.47M | -14.75M | -13.81M | -15.94M | -13.43M |
Net Income | -21.75M | -15.05M | -14.46M | -13.62M | -11.99M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 17.74M | 29.69M | 21.27M | 23.84M | 25.5M |
Total Liabilities | 44.57M | 49.24M | 44.47M | 59.51M | 46.51M |
Total Equity | -26.83M | -19.55M | -23.2M | -35.67M | -21.01M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -15.16M | -13.51M | -17.18M | -17.47M | -16.87M |
Investing | -433k | -277k | -590k | -360k | -614k |
Financing | 9.73M | 28.73M | 5.84M | 16.39M | 16.27M |
Market Cap | 41.14M |
Price to Earnings Ratio | -3.43 |
Price to Sales Ratio | 42.47 |
Price to Cash Ratio | 6.78 |
Price to Book Ratio | -1.96 |
Dividend Yield | - |
Shares Outstanding | 52.07M |
Average Volume (1 week) | 54.3k |
Average Volume (1 Month) | 40.04k |
52 Week Change | -72.66% |
52 Week High | 4.465 |
52 Week Low | 0.79 |
Spread (Intraday) | 0.02 (2.47%) |
Company Name | Ab Science |
Address |
3 avenue george v paris, paris 75008 |
Website | https://www.ab-science.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.